We report a patient with Crohn's disease who developed metastatic cutaneous lesions and granulomatous cheilitis, two rare cutaneous manifestations ofCrohn's disease.
Case report
A 15-year-old boy presented in 1980with pronounced swelling of his lower lip. A biopsy of the lip showed the corium to be infiltrated with chronic inflammatory cells and there were multiple foci of epithelioid granulomas which contained Langhans' giant cells. The clinical and histological features were thought to be compatible with either oral Crohn's disease or the Melkersson-Rosenthal syndrome. As the patient was asymptomatic and the swelling of the lip had decreased spontaneously, no further investigations were carried out. He represented in October 1983 with a rash on his lower legs. For nine months he had had weight loss, diarrhoea and abdominal pain. Examination showed purple, crusted nodules on the lower leg ( Figure 1 ). The patient was also noted to have an anal fissure. Investigations showed a haemoglobin of 13.0g/100 ml, ESR of 50 mm in one hour, normal chest X-ray and a negative Mantoux test (100units PPD). A barium meal and follow through showed coarsening of the mucosal pattern in the terminal ileum. A barium enema showed spasm of all segments of the colon and coarsening of the mucosal pattern. Although the X-ray appearances were compatible with either ulcerative colitis or Crohn's disease, the extent of the small bowel involvement favoured a diagnosis of Crohn's disease. A skin biopsy from the leg showed non-caseating granulomas within the dermis (Figure 2 ), extending into the subcutaneous fat; some of the granulomas were arranged perivascu-larly and others periadnexally. The vessels which were surrounded by granulomas showed vasculitic changes. An area of eosinophilic necrosis of collagen was present in the mid-dermis and was surrounded by non-caseating granulomas. Special stains and cultures for organisms were negative.
The patient was treated with prednisolone 40 mg and sulphasalazine 1 g four times daily. His bowel symptoms rapidly improved and the skin nodules healed over a period of months. In October 1984, whilst the patient was taking prednisolone 10mg, his bowel disease relapsed and he developed further nodules on his legs. The prednisolone was increased to 30 mg daily and the skin nodules healed in two months.
Discussion
This patient developed two rare cutaneous manifestations of Crohn's disease: metastatic Crohn's disease and granulomatous cheilitis. The dermatological manifestations of Crohn's disease can be Two types of granulomatous skin lesions are recognized in Crohn's disease, the most common being cutaneous involvement which is a direct extension of the inflammation of the bowel; this may occur perianally or around stoma sites and fistulae. In contrast, metastatic cutaneous Crohn's disease is a term used to describe lesions which have a granulomatous histology and are remote from the bowel. These lesions have a variable clinical appearance; early reports described ulcers in flexural sites 1 • 2 but ulcers at non-flexural sites have also been reported 3 -S • Two other morphological types have been described -a nodular variety in which lesions usually appear on the extremities 6 -9 and a form in which there are generalized lichenoid papulea'P:'.'. Metastatic lesions are associated with disease that involves the colon, which is in keeping with the observation that theextraintestinal complications of Crohn's disease are more commonly associated with colonic disease 12 • Although oral and cutaneous lesions may either precede or follow the onset of bowel involvement in Crohn's disease, metastatic lesions almost always follow the onset of gastrointestinal disease. We have only been able to trace one case in which metastatic lesions have appeared prior to the development of clinical or radiological evidence of bowel diaease!".
Histologically these lesions usually show noncaseating granulomas within the dermis, occasionally extending into the subcutaneous tissue. In some cases the granulomas were arranged perivascularly but the vessel walls were normal'v": in others this arrangement of granulomas has been associated with a vasculitis": 14.15, changes which have been referred to as a granulomatous perivasculitis. It has been suggested that the perivascular arrangement of the granulomas may be attributed to the deposition of circulating antigens or immune complexes within the skin16. In our patient some of the granulomas showed a perivascular arrangement and the surrounded vessels showed a vasculitis. These vascular changes were considered to be secondary to the granulomatous inflammation and probably did not represent a primary vasculitis.
There is no consistent relationship between the appearance of the metastatic lesions and the activity of the bowel disease. Although in our patient the lesions tended to appear when the gastrointestinal disease was active, other reports have described the lesions appearing when the bowel disease was quiescent!". Unlike cutaneous lesions which are contiguous with bowel disease, metastatic cutaneous Crohn's disease does not usually pose a difficult therapeutic problem. Lesions may resolve spontaneously or readily respond to systemic or topical steroids; one case report describes slow clearing of these lesions with dapsone", Granulomatous cheilitis, like other forms of oral Crohn's disease, may precede, coincide with or follow the onset of gastrointestinal disease. In the absence of bowel disease it may be difficult to distinguish Crohn's cheilitis from the Melkersson-Rosenthal syndrome which although characterized by granulomatous cheilitis, cranial nerve palsies and a scrotal tongue, may occur in incomplete forms in which only the cheilitis is present!". Crohn's cheilitis is difficult to treat; the lesions rarely respond to systemic steroids, azathioprine and sulphasalazine, and intralesionalsteroids are usually the most effective form of therapy. It is interesting to note that in this patient the cheilitis improved spontaneously, leaving only residual thickening which has not been altered by any subsequent anti-Crohn's therapy.
Small bowel adenocarcinomas with coincidental
Crohn's disease have been reported on many occasiona'P. It is, however, a matter of controversy as to whether this association is anything more than chance. Collier et al,", in their review of small intestinal adenocarcinoma complicating regional enteritis, described certain features of the adenocarcinomas in these cases which differentiated them from de novo adenocarcinomas. The following report illustrates many of these distinguishing features.
Case report A 42.year-old male Caucasian with a 12-year history of Crohn's disease presented with a 6·month history of increasing colicky abdominal pain and vomiting eventually resulting in frank small bowel obstruction. His medication at the time was salazopyrine 500 mg four times daily and prednisolone 8 mg per day.
On examination there was a firm, tender mass in the right iliac fossa. Erect abdominal X-rays showed multiple small bowel fluid levels. Laparotomy revealed dilated small bowel proximal to a hard constricting lesion in the ileum. Distal to this was a 5 em length of grossly thickened bowel. There were multiple nodules over the serosal coat of the small bowel, and further nodules seeding the pelvic peritoneum. The liver at laparotomy was clear of tumour. The stricture was resected and an end-to-end anastomosis performed.
The histology of the stricture revealed a poorly differentiated adenocarcinoma of the small bowel ( Figure 1 ).The full thickness of the wall was involved to the serosa, with tumour present in the veins. Adjacent bowel showed features of Crohn's disease ( Figure 2) . Biopsies of the serosal nodules demonstrated further adenocarcinoma of small bowel origin.
Two further laparotomies were performed 3 and 6 months after presentation for small bowel obstruction. The patient died one month after the last laparotomy.
Discussion
This case illustrates several of the features that were reported by Collier et al. 1, in their review of 78 cases, to differentiate between small bowel adenocarcinoma complicating Crohn's disease, and de novo small bowel adenocarcinoma.
Firstly, at 42 the patient was relatively young; the average age of patients with Crohn's disease is 46.5 years compared with 64.6years for de novo adenocarcinoma. Secondly, the patient was male, there being a 3:1 male:female predominance in Crohn's disease as opposed to 1:1 for de novo cases. Thirdly, the lesion 0141-0768/87/ 010051-02/$02.00/0 el987 The Royal Society of Medicine
